- Home
- GENK vs BNGO Comparison
GENK vs BNGO Comparison
Compare GENK & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GENK
- BNGO
- Stock Information
- Founded
- GENK 2011
- BNGO 2003
- Country
- GENK United States
- BNGO United States
- Employees
- GENK N/A
- BNGO N/A
- Industry
- GENK Restaurants
- BNGO Biotechnology: Laboratory Analytical Instruments
- Sector
- GENK Consumer Discretionary
- BNGO Industrials
- Exchange
- GENK Nasdaq
- BNGO Nasdaq
- Market Cap
- GENK 20.4M
- BNGO 24.3M
- IPO Year
- GENK 2023
- BNGO 2018
- Fundamental
- Price
- GENK $3.73
- BNGO $3.27
- Analyst Decision
- GENK Strong Buy
- BNGO Buy
- Analyst Count
- GENK 2
- BNGO 5
- Target Price
- GENK $10.00
- BNGO $7.33
- AVG Volume (30 Days)
- GENK 105.8K
- BNGO 78.6K
- Earning Date
- GENK 07-30-2025
- BNGO 08-06-2025
- Dividend Yield
- GENK 0.82%
- BNGO N/A
- EPS Growth
- GENK N/A
- BNGO N/A
- EPS
- GENK N/A
- BNGO N/A
- Revenue
- GENK $214,957,000.00
- BNGO $28,464,000.00
- Revenue This Year
- GENK $16.62
- BNGO N/A
- Revenue Next Year
- GENK $20.40
- BNGO $15.54
- P/E Ratio
- GENK N/A
- BNGO N/A
- Revenue Growth
- GENK 14.40
- BNGO N/A
- 52 Week Low
- GENK $3.16
- BNGO $2.68
- 52 Week High
- GENK $10.33
- BNGO $44.94
- Technical
- Relative Strength Index (RSI)
- GENK 42.84
- BNGO 43.73
- Support Level
- GENK $3.50
- BNGO $3.18
- Resistance Level
- GENK $3.78
- BNGO $3.47
- Average True Range (ATR)
- GENK 0.26
- BNGO 0.17
- MACD
- GENK -0.01
- BNGO -0.01
- Stochastic Oscillator
- GENK 22.64
- BNGO 36.67
About GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc operates an Asian casual dining restaurant chain, offering an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables. It operates 43 Gen Korean BBQ restaurants in the United States.
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.